banner image

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Nov 3, 2022
Document Date
Sep 30, 2022
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Keros Therapeutics
Issuer
Keros Therapeutics, Inc.
Follicular_Lymphoma_in_Bone_Marrow image